Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

Phase 3 Unknown 600 enrolled University of Turin, Italy

RandomizedParallel-groupOpen-labelTreatment

Summary

The study includes the recruitment of patients with advanced prostate cancer resistant to chemical castration This is a multicenter prospective trial randomized phase III

Timeline

Start: 2010-04
Primary completion: 2010-08
Completion: 2016-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Docetaxel	Small molecule	75 mg/m2	Intravenous

Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

Summary

Timeline

Drugs

Indications